212 related articles for article (PubMed ID: 21344157)
1. Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis.
Katayama A; Takahara M; Kishibe K; Nagato T; Kunibe I; Katada A; Hayashi T; Harabuchi Y
Int J Oncol; 2011 May; 38(5):1219-26. PubMed ID: 21344157
[TBL] [Abstract][Full Text] [Related]
2. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.
Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H
Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044
[TBL] [Abstract][Full Text] [Related]
3. B7-H3 and B7-H4 expression in non-small-cell lung cancer.
Sun Y; Wang Y; Zhao J; Gu M; Giscombe R; Lefvert AK; Wang X
Lung Cancer; 2006 Aug; 53(2):143-51. PubMed ID: 16782226
[TBL] [Abstract][Full Text] [Related]
4. Delayed regional metastases, distant metastases, and second primary malignancies in squamous cell carcinomas of the larynx and hypopharynx.
Spector JG; Sessions DG; Haughey BH; Chao KS; Simpson J; El Mofty S; Perez CA
Laryngoscope; 2001 Jun; 111(6):1079-87. PubMed ID: 11404625
[TBL] [Abstract][Full Text] [Related]
5. B7-H3 expression in gastric cancer: a novel molecular blood marker for detecting circulating tumor cells.
Arigami T; Uenosono Y; Hirata M; Yanagita S; Ishigami S; Natsugoe S
Cancer Sci; 2011 May; 102(5):1019-24. PubMed ID: 21251161
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of costimulatory molecule B7-H3 mRNA and B7-H3 protein in gastric carcinoma].
Zhao JM; Wu CP; Wang RC; Xu J; Zhu J; Wei J; Luo GH; Shi LR; Tan M; Tan Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):458-62. PubMed ID: 17851789
[TBL] [Abstract][Full Text] [Related]
7. Transgenic B7-H3 therapy induces tumor-specific immune response in human oral squamous cell cancer: an in vitro study.
Yang HY; Chu M; Zheng LW; Zwahlen RA; Luo J; Zou DH; Sun ST
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Nov; 106(5):721-8. PubMed ID: 18929994
[TBL] [Abstract][Full Text] [Related]
8. Human muscle cells express the costimulatory molecule B7-H3, which modulates muscle-immune interactions.
Waschbisch A; Wintterle S; Lochmüller H; Walter MC; Wischhusen J; Kieseier BC; Wiendl H
Arthritis Rheum; 2008 Nov; 58(11):3600-8. PubMed ID: 18975328
[TBL] [Abstract][Full Text] [Related]
9. [Regional failure of hypopharyngeal squamous cell carcinoma].
Oueslati Z; Zeglaoui I; Touati S; Gritli S; Mokni N; Nasr C; Boussen H; El-Benna F; Gamoudi A; El-May A; Ladgham A
Cancer Radiother; 2004 Dec; 8(6):352-7. PubMed ID: 15619379
[TBL] [Abstract][Full Text] [Related]
10. B7-h4 expression in human melanoma: its association with patients' survival and antitumor immune response.
Quandt D; Fiedler E; Boettcher D; Marsch WCh; Seliger B
Clin Cancer Res; 2011 May; 17(10):3100-11. PubMed ID: 21378130
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.
Badoual C; Hans S; Rodriguez J; Peyrard S; Klein C; Agueznay Nel H; Mosseri V; Laccourreye O; Bruneval P; Fridman WH; Brasnu DF; Tartour E
Clin Cancer Res; 2006 Jan; 12(2):465-72. PubMed ID: 16428488
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of costimulatory molecule B7-H3 expression on CD3(+) T cells in colorectal carcinoma.
Mao Y; Sun J; Wang WP; Zhang XG; Hua D
Chin Med J (Engl); 2013 Aug; 126(16):3035-8. PubMed ID: 23981607
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma.
Watanabe Y; Katou F; Ohtani H; Nakayama T; Yoshie O; Hashimoto K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):744-52. PubMed ID: 20303300
[TBL] [Abstract][Full Text] [Related]
14. B7-H3 and CD133 expression in non-small cell lung cancer and correlation with clinicopathologic factors and prognosis.
Xu YH; Zhang GB; Wang JM; Hu HC
Saudi Med J; 2010 Sep; 31(9):980-6. PubMed ID: 20844808
[TBL] [Abstract][Full Text] [Related]
15. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy.
Thompson RH; Dong H; Kwon ED
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):709s-715s. PubMed ID: 17255298
[TBL] [Abstract][Full Text] [Related]
16. Expression of RCAS1 in esophageal squamous cell carcinoma is associated with a poor prognosis.
Kato H; Nakajima M; Masuda N; Faried A; Sohda M; Fukai Y; Miyazaki T; Fukuchi M; Tsukada K; Kuwano H
J Surg Oncol; 2005 May; 90(2):89-94. PubMed ID: 15844180
[TBL] [Abstract][Full Text] [Related]
17. PD-1 is expressed by tumor-infiltrating immune cells and is associated with poor outcome for patients with renal cell carcinoma.
Thompson RH; Dong H; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1757-61. PubMed ID: 17363529
[TBL] [Abstract][Full Text] [Related]
18. Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.
Krambeck AE; Dong H; Thompson RH; Kuntz SM; Lohse CM; Leibovich BC; Blute ML; Sebo TJ; Cheville JC; Parker AS; Kwon ED
Clin Cancer Res; 2007 Mar; 13(6):1749-56. PubMed ID: 17363528
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of serum T-lymphocyte subsets and NK cell activity in patients with hypopharyngeal squamous cell carcinoma].
Chen WK; Song M; Chen FJ; Guo ZM; He LR; Yan SL
Ai Zheng; 2006 Oct; 25(10):1300-2. PubMed ID: 17059781
[TBL] [Abstract][Full Text] [Related]
20. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression.
Konishi J; Yamazaki K; Azuma M; Kinoshita I; Dosaka-Akita H; Nishimura M
Clin Cancer Res; 2004 Aug; 10(15):5094-100. PubMed ID: 15297412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]